William P. Forbes, EVP Research&Devel & CDO at SALIX PHARMACEUTICALS LTD (SLXP), sold 12,000 shares at $71.88 ($851K) on 2013-07-24, disclosed to the SEC on 2013-07-26.
Scheduled sale ($851k) by EVP Research&Devel & CDO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.91 | 3,000 | $210K | 24.6% |
| 2 | $70.96 | 6,000 | $426K | 50.0% |
| 3 | $71.88 | 3,000 | $216K | 25.3% |
| Total | $70.93 avg | 12,000 | $851K | 100% |
| Filing → |
| XAIR | BUY | 2023-04-03 | $33K | — | Filing → |
| XAIR | BUY | 2023-03-20 | $32K | — | Filing → |
| XAIR | BUY | 2019-11-15 | $25K | — | Filing → |